WELCOME TO PNEUMOWAVE
Revolutionizing the use of wearable motion sensing to improve understanding and treatment of life-threatening conditions
By harnessing the potential of advanced data analytics, we empower timely interventions that can save lives
Product Pipeline
PneumoWave has developed an integrated platform for patient data capture and analysis, with a pipeline of products based on our custom designed, small, chest-worn biosensor:
DCM
DCM is an activity monitor for documenting physical movement during sleep and other activities.
ALERT
ALERT is our solution for real-time monitoring of opioid induced respiratory depression and other life threatening conditions.
Our solutions aim to facilitate a paradigm shift in patient care, focusing on intervention before disease or injury has advanced.
Our Team
£5.2 m equity from Scottish National Investment Bank alongside £2.3 m from existing investors Scottish Enterprise, IIG, London & Scottish…
January 12, 2023
Digital therapeutics company PneumoWave (formerly known as Altair Medical) announced today the use of their monitoring platform in a clinical trial led by Professor Sir John Strang at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.
Press Release
January 19, 2022
Tuesday 2nd November Digital therapeutics company PneumoWave (formerly known as Altair Medical) announced today the commencement of a second clinical…
Press Release
November 2, 2021
PneumoWave Takes Part in UK Government’s Reducing Drug Deaths Innovation Challenge
[Glasgow, Scotland – Thursday 31st October, 2024] https://www.gov.uk/government/news/virtual-reality-and-wearable-technology-pilot-to-cut-drug-deaths Government awards £12 million to research projects across the UK that are researching innovative technology to support people with addictions. PneumoWave are...
Read MorePneumoWave, King’s College London, Uniting MSIC Sydney and Royal Melbourne Hospital Publish Protocol for Observational Study in Supervised Injecting Facility
[Glasgow, Scotland – Monday 23rd September, 2024] https://www.researchprotocols.org/2024/1/e57367 A joint paper was published in JMIR Research Protocols, vol 13 (2024), detailing the OD-SEEN (Overdose Sensor Detection amongst high-risk opioid users...
Read MorePneumoWave Achieves Major Milestones with ISO13485:2016 Certification and UKCA Class 1 Registration.
PneumoWave, an innovator in the fight against the opioidepidemic, is proud to announce that it has achieved ISO 13485:2016 certification and has registered aversion of its technology as a Class...
Read MoreContact Us
Please contact us with any enquiries. We will aim to respond to your query as soon as possible.
UK Location
PneumoWave, LTD
Suites 3 and 4
Second Floor, Maxim 3
Maxim Office Park
Parklands Avenue
Eurocentral ML1 4WQ
UK
USA Location(s)
PneumoWave, Inc.
4900 O’Hear Avenue, Suite 100,
PMB# 511
North Charleston, SC 29405
USA
PneumoWave, Inc.
421 Fayetteville Street, Suite 1100,
Raleigh, NC 27601
USA